Skip to Primary Navigation

Skip to main content

Trump administration issues new policy to halt DGoF research

A photo of President Donald Trump in profile, with his mouth hanging open while gesturing forward with his hand outstretched.
Photo: Chip Somodevilla/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The new White House policy bans federal funding for dangerous gain of function research and reshapes oversight for high-risk science.

The White House and the US Department of Health and Human Services (HHS) have announced a new federal policy prohibiting federal funding of dangerous gain‑of‑function (DGoF) research, replacing previous oversight frameworks with stricter safeguards designed to protect public health, biosecurity, and national security.

DGoF research involves modifying pathogens

, , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience